The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 16th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Public Reporting of PCI and its Affect on Patient Care
With New York and Massachusetts leading the way laws requiring public reporting of PCI results were recently expanded to Washington State as well. A recent study looked at the risks and benefits of other states starting similar programs.
Lines Blurred on "Normal" Testosterone Level, Physicians Prescribe Therapy Without Need
A new analysis of insurance company records indicates that doctors frequently give testosterone therapy to men with "normal" hormone levels and that they fail, more often than not, to screen patients for prostate cancer each year.
Study Finds No Convincing Evidence of Increased Cardiovascular Risk with Testosterone Therapy
A review of research conducted over the past 75 years finds no definitive answers about the link between testosterone supplements and cardiovascular health, but it does find far more evidence of benefit than harm.
Moving Medicine Onto a Digital Platform
Patient care continues to make dramatic changes including the way information is shared not only between doctors and patients, but also other doctors treating the same people. Technology making that happen continues to evolve as well.
BMI Matters: Predicting Cardiovascular Event Risk
While various epidemiological studies have shown obesity to be linked with inflammation and with increased cardiovascular risk, the inflammatory marker C-reactive protein (CRP) takes it a step further, strongly predicting the incidence of cardiovascular events.
Comprehensive Health Model Provides Prediabetes Reversal
A recent Centers for Disease Control and Prevention (CDC) study revealed 86 million Americans suffer from prediabetes, a modifiable risk factor for cardiovascular disease (CVD), and nearly half of prediabetic patients were reported to develop frank diabetes.
Impact of Medication Adherence on Diabetic Patients
Chronic illness treatment typically involves some level of long-term use of pharmacotherapy. While these medications may prove efficacious in contesting the disease, their full benefits often go unmet, because nearly 50% of patients do not to take the medications as prescribed.
Endocrine Society President Discusses Current State and Future of the Field
Like most medical fields endocrinology has seen changes in doctor recruitment, patient relationships, and overall care. The future of the field is discussed by the president of the Endocrine Society
Working to Improve Care for Transgender Youth
Childhood can be a stressful enough time without the impact of outside influences and other factors. Healthcare professionals around the country are working to ensure that young gender dysphoria patients get the care and help they need in their process.
Explaining the Link Between Diabetes, Anxiety, and Depression
March 11th 2015Researchers from Joslin Diabetes Center at Harvard Medical School may have uncovered an explanation for why patients with diabetes are more likely to develop anxiety and depression than patients with other chronic conditions requiring similar levels of management.
Testosterone Replacement Therapy Not Associated with Increased Risk of Cardiovascular Events in Men
March 9th 2015Study results show that men with stable coronary heart disease or acute coronary syndrome who received testosterone replacement therapy did not experience higher rates of major adverse cardiovascular events than men who did not receive testosterone replacement therapy.